Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07754591
Comparison of Dynamic Compliance and Airway Resistance in Pressure-Controlled Versus Volume-Controlled Ventilation in Children Undergoing Corrective Heart SurgeryNilratan Sircar Medical CollegeCompletedNot Applicable
NCT07754591Completed
Not Applicable
Comparison of Dynamic Compliance and Airway Resistance in Pressure-Controlled Ve...Nilratan Sircar Medical C...
NCT07754318
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic CardiovascularNot Yet RecruitingNot Applicable
NCT07754318Not Yet Recruiting
Not Applicable
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic Cardiovascular
NCT07755020
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial HospitalRecruiting
NCT07755020Recruiting
—
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial Hosp...
NCT07754526
OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care Treatment Alone.Omeza, LLCNot Yet RecruitingNot Applicable
NCT07754526Not Yet Recruiting
Not Applicable
OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care T...Omeza, LLC
NCT07756411
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Open-angle Glaucoma.University of UdineCompletedNot Applicable
NCT07756411Completed
Not Applicable
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Ope...University of Udine
NCT07756645
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult ParticipantsAbbVieNot Yet RecruitingPhase 3
NCT07756645Not Yet Recruiting
Phase 3
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembro...AbbVie
NCT07755540
Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomized Controlled TrialDrexel UniversityRecruitingPhase 2
NCT07755540Recruiting
Phase 2
Group Music Therapy for Chronic Pain Management in Active Duty Service Members:...Drexel University
NCT07754279
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica HoldingCompletedPhase 1
NCT07754279Completed
Phase 1
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica Holding
NCT07755917
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile HealthDongying People's HospitalNot Yet RecruitingNot Applicable
NCT07755917Not Yet Recruiting
Not Applicable
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Inte...Dongying People's Hospita...
NCT07755527
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement - Open TrialHenry Ford Health SystemNot Yet RecruitingNot Applicable
NCT07755527Not Yet Recruiting
Not Applicable
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement...Henry Ford Health System
NCT07754487
Turkish Adaptation and Validation of the Adolescents and Adults Coordination QuestionnaireGulser CINBAZNot Yet Recruiting
NCT07754487Not Yet Recruiting
—
Turkish Adaptation and Validation of the Adolescents and Adults Coordination Que...Gulser CINBAZ
NCT07754084
Comprehensive Clinical Prediction Rule for Acute Heart FailureChinese University of Hong KongNot Yet Recruiting
NCT07754084Not Yet Recruiting
—
Comprehensive Clinical Prediction Rule for Acute Heart FailureChinese University of Hon...
NCT07754149
Dose-Response Effects of a 6-Week Progressive Resistance Training Program on Premenstrual Syndrome in Adolescent GirlsRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07754149Not Yet Recruiting
Not Applicable
Dose-Response Effects of a 6-Week Progressive Resistance Training Program on Pre...Riphah International Univ...
NCT07755397
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorJubilant Therapeutics India LimitedRecruitingPhase 1
NCT07755397Recruiting
Phase 1
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Stud...Jubilant Therapeutics Ind...
NCT07754760
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availability Following a Standard-protein Breakfast in Older AdultsLeeds Beckett UniversityCompletedNot Applicable
NCT07754760Completed
Not Applicable
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availabil...Leeds Beckett University
NCT07756138
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexStanford UniversityNot Yet RecruitingPhase 2
NCT07756138Not Yet Recruiting
Phase 2
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexStanford University
NCT07754162
Inter-Rater Reliability of Ultra Sound Based Rectus Abdominis Thickness Following Blood Flow Restriction TrainingRiphah International UniversityRecruiting
NCT07754162Recruiting
—
Inter-Rater Reliability of Ultra Sound Based Rectus Abdominis Thickness Followin...Riphah International Univ...
NCT07755605
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder: A Randomized Controlled TrialSamsung Medical CenterRecruitingNot Applicable
NCT07755605Recruiting
Not Applicable
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Dis...Samsung Medical Center
NCT07754474
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07754474Not Yet Recruiting
Phase 1
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerate...Boehringer Ingelheim
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed4 (20%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)